{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:46:26Z","timestamp":1789613186798,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0905800"],"award-info":[{"award-number":["2016YFC0905800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["Q2017001"],"award-info":[{"award-number":["Q2017001"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970031"],"award-info":[{"award-number":["81970031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700028"],"award-info":[{"award-number":["81700028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671563"],"award-info":[{"award-number":["81671563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770031"],"award-info":[{"award-number":["81770031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171501"],"award-info":[{"award-number":["BK20171501"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20181497"],"award-info":[{"award-number":["BK20181497"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK2017080"],"award-info":[{"award-number":["BK2017080"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.tranon.2022.101564","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T08:47:57Z","timestamp":1665737277000},"page":"101564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells"],"prefix":"10.1016","volume":"27","author":[{"given":"Jingjing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-0168","authenticated-orcid":false,"given":"Mingshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2022.101564_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2022.101564_bib0002","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1590\/S1807-59322008000500012","article-title":"Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization","volume":"63","author":"Aguiar","year":"2008","journal-title":"Clinics"},{"key":"10.1016\/j.tranon.2022.101564_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2012.07.010","article-title":"A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells","volume":"40","author":"Hillhouse","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tranon.2022.101564_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.kint.2022.02.035","article-title":"TCRalphabeta+ CD4-\/CD8- \u201cdouble negative\u201d T cells in health and disease-implications for the kidney","volume":"102","author":"Newman-Rivera","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.tranon.2022.101564_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40425-019-0507-2","article-title":"Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15","volume":"7","author":"Yao","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0006","doi-asserted-by":"crossref","first-page":"eabl3642","DOI":"10.1126\/sciimmunol.abl3642","article-title":"Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities","volume":"7","author":"Vasic","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tranon.2022.101564_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-021-01312-y","article-title":"Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0008","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/biom11111606","article-title":"Diagnostic and prognostic utility of the extracellular vesicles subpopulations present in pleural effusion","volume":"11","author":"Javadi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2022.101564_bib0009","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.7150\/jca.39717","article-title":"DNT Cell-based Immunotherapy: progress and applications","volume":"11","author":"Li","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0010","first-page":"3747","article-title":"Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions","volume":"30","author":"Wada","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tranon.2022.101564_bib0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2003-0238OC","article-title":"Proteomic analysis of exosomes isolated from human malignant pleural effusions","volume":"31","author":"Bard","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tranon.2022.101564_bib0012","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/pmic.201200323","article-title":"Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions","volume":"13","author":"Park","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.tranon.2022.101564_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted therapy and checkpoint immunotherapy in lung cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.tranon.2022.101564_bib0014","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1158\/1078-0432.CCR-16-2821","article-title":"Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8(+) T-cell infiltration","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101564_bib0015","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","article-title":"A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer","volume":"59","author":"Iliopoulou","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tranon.2022.101564_bib0016","doi-asserted-by":"crossref","first-page":"e001185","DOI":"10.1136\/jitc-2020-001185","article-title":"Adoptive transfer of zoledronate-expanded autologous Vgamma9Vdelta2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study","volume":"8","author":"Kakimi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0017","article-title":"Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent","volume":"12","author":"Zhu","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tranon.2022.101564_bib0018","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.7150\/jca.39717","article-title":"DNT Cell-based immunotherapy: progress and applications","volume":"11","author":"Li","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-065X.1996.tb00906.x","article-title":"Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity","volume":"149","author":"Strober","year":"1996","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tranon.2022.101564_bib0020","first-page":"8387","article-title":"Elevated peripheral blood B lymphocytes and CD3(+)CD4(-)CD8(-) T lymphocytes in patients with non-small cell lung cancer: a preliminary study on peripheral immune profile","volume":"15","author":"Liang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2022.101564_bib0021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13046-019-1126-y","article-title":"Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade","volume":"38","author":"Fang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101564_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/CBM-190201","article-title":"Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma","volume":"26","author":"Ren","year":"2019","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.tranon.2022.101564_bib0023","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/cells10020406","article-title":"Examining the relationship between circulating CD4- CD8- double-negative T cells and outcomes of immuno-checkpoint inhibitor therapy-looking for biomarkers and therapeutic targets in metastatic melanoma","volume":"10","author":"Strippoli","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tranon.2022.101564_bib0024","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.4049\/jimmunol.167.11.6188","article-title":"TCR\/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells","volume":"167","author":"Priatel","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.tranon.2022.101564_bib0025","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.177.5.2803","article-title":"Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors","volume":"177","author":"Ford","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.tranon.2022.101564_bib0026","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1073\/pnas.042692799","article-title":"Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tranon.2022.101564_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2014.10.007","article-title":"The DNA methylation signature of human TCR\u03b1\u03b2+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response","volume":"156","author":"Renauer","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tranon.2022.101564_bib0028","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2013.06.011","article-title":"Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells","volume":"284","author":"Grishkan","year":"2013","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.tranon.2022.101564_bib0029","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pan.2018.12.006","article-title":"Antipancreatic cancer effect of DNT cells and the underlying mechanism","volume":"19","author":"Chen","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.tranon.2022.101564_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1078-0432.CCR-17-2228","article-title":"Allogeneic human double negative T cells as a novel immunotherapy for acute myeloid leukemia and its underlying mechanisms","volume":"24","author":"Lee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101564_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40425-019-0507-2","article-title":"Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15","volume":"7","author":"Yao","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13046-019-1126-y","article-title":"Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade","volume":"38","author":"Fang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101564_bib0033","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1790158","article-title":"Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy","volume":"9","author":"Luo","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.tranon.2022.101564_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2022.101564_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-017-0269-7","article-title":"Tumor-derived exosomes induce CD8(+) T cell suppressors","volume":"5","author":"Maybruck","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0036","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/cancers13030473","article-title":"The interplay of exosomes and NK cells in cancer biology","volume":"13","author":"Batista","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101564_bib0037","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.18632\/oncotarget.20812","article-title":"Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2022.101564_bib0038","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-018-0898-6","article-title":"Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0039","article-title":"CEACAM1 as a multi-purpose target for cancer immunotherapy","volume":"6","author":"Dankner","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.tranon.2022.101564_bib0040","first-page":"A119","article-title":"Preclinical characterization and development of MG1124, a novel immune checkpoint inhibitor targeting CEACAM1 for NSCLC patients","volume":"8","author":"Lee","year":"2019","journal-title":"J. Immun. Ther. Cancer"},{"key":"10.1016\/j.tranon.2022.101564_bib0041","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1038\/s41467-019-13316-w","article-title":"Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles","volume":"10","author":"Xie","year":"2019","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1016\/j.tranon.2024.102205","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:26:41Z","timestamp":1761845201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523322002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"alternative-id":["S1936523322002236"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101564","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101564"}}